Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 14150 | 723 | 33.8 | 74% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 469 | 15101 | BRONCHOPULMONARY DYSPLASIA//PULMONARY SURFACTANT//RESPIRATORY DISTRESS SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CHRONIC LUNG DISEASE | Author keyword | 15 | 14% | 13% | 97 |
| 2 | POSTNATAL STEROIDS | Author keyword | 6 | 80% | 1% | 4 |
| 3 | EARLY DEXAMETHASONE THERAPY | Author keyword | 6 | 100% | 1% | 4 |
| 4 | ANTI INFLAMMATORY AGENTS ADVERSE EFFECTS THERAPEUTIC USE | Author keyword | 4 | 75% | 0% | 3 |
| 5 | POSTNATAL CORTICOSTEROIDS | Author keyword | 4 | 75% | 0% | 3 |
| 6 | LOW DOSE DEXAMETHASONE | Author keyword | 3 | 57% | 1% | 4 |
| 7 | PRINCE WALES HOSP CHEM PATHOL | Address | 3 | 100% | 0% | 3 |
| 8 | ANAT PHYSIOL CHILDREN ADOLESCENTS | Address | 2 | 67% | 0% | 2 |
| 9 | BECLOMETHASONE ADMINISTRATION DOSAGE | Author keyword | 2 | 67% | 0% | 2 |
| 10 | LIMBIC HYPOTHALAMIC PITUITARY ADRENAL AXIS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DEPENDENT INFANTS | 89 | 78% | 8% | 58 |
| 2 | 42 DAY TAPERING COURSE | 68 | 100% | 3% | 22 |
| 3 | EARLY ADRENAL INSUFFICIENCY | 54 | 71% | 6% | 44 |
| 4 | EARLY POSTNATAL DEXAMETHASONE | 47 | 81% | 4% | 29 |
| 5 | VENTILATOR DEPENDENCY | 41 | 90% | 2% | 18 |
| 6 | CHRONIC LUNG DISEASE | 31 | 11% | 35% | 252 |
| 7 | POSTNATAL CORTICOSTEROIDS | 24 | 63% | 3% | 24 |
| 8 | POSTNATAL DEXAMETHASONE THERAPY | 18 | 67% | 2% | 16 |
| 9 | DEXAMETHASONE THERAPY | 12 | 22% | 7% | 50 |
| 10 | PROTEINASE INHIBITOR COMPLEX | 12 | 86% | 1% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants | 2009 | 44 | 52 | 96% |
| Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants | 2010 | 42 | 57 | 86% |
| Dexamethasone Treatment after the First Week of Life for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review | 2010 | 34 | 34 | 97% |
| Postnatal Hydrocortisone for Preventing or Treating Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review | 2010 | 35 | 22 | 77% |
| Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants | 2014 | 2 | 96 | 89% |
| Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants | 2009 | 31 | 55 | 89% |
| Dexamethasone Treatment in the First Week of Life for Preventing Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review | 2010 | 27 | 27 | 85% |
| Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials | 2009 | 24 | 35 | 83% |
| Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function | 2000 | 39 | 23 | 96% |
| Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates | 2007 | 26 | 21 | 62% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PRINCE WALES HOSP CHEM PATHOL | 3 | 100% | 0.4% | 3 |
| 2 | ANAT PHYSIOL CHILDREN ADOLESCENTS | 2 | 67% | 0.3% | 2 |
| 3 | NEONATAL PEDIAT INTENS CARE SERV | 2 | 67% | 0.3% | 2 |
| 4 | ROYAL JUBILEE MATERN SERV | 1 | 27% | 0.4% | 3 |
| 5 | FUNCT NEUROGEN | 1 | 20% | 0.6% | 4 |
| 6 | BOSTON FLOATING HOSP CHILDREN | 1 | 33% | 0.3% | 2 |
| 7 | REG NEONATAL UNIT | 1 | 11% | 0.8% | 6 |
| 8 | AUBREY MARLA DAN PROGRAM HIGH RISK MOTHERS BA | 1 | 50% | 0.1% | 1 |
| 9 | CAREGGI UNIV HOSPSECT NEONATOL | 1 | 50% | 0.1% | 1 |
| 10 | CELL BIOL ANATREG NEONATAL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000296681 | ANTENATAL CORTICOSTEROIDS//BETAMETHASONE//ANTENATAL GLUCOCORTICOIDS |
| 2 | 0.0000293941 | BRONCHOPULMONARY DYSPLASIA//CHRONIC LUNG DISEASE//ALVEOLARIZATION |
| 3 | 0.0000121112 | FETAL NEONATAL MED//NEONATAL BLOOD PRESSURE//TRANSCEPHALIC ELECTRICAL IMPEDANCE |
| 4 | 0.0000085493 | STUDIES REPROD//MED STUDIES REPROD PHYSIOL//FETAL ZONE |
| 5 | 0.0000067476 | ADRENAL INSUFFICIENCY//RELATIVE ADRENAL INSUFFICIENCY//LOW DOSE ACTH TEST |
| 6 | 0.0000066256 | HIGH FLOW NASAL CANNULA//BUBBLE CPAP//INSURE |
| 7 | 0.0000057260 | NON PROTEIN BOUND IRON//HUMAN NUTR SCI PAEDIAT//TOTAL HYDROPEROXIDE |
| 8 | 0.0000056947 | TCHRF//VITAMIN A THERAPEUTIC USE//ALVEOLAR REGENERATION |
| 9 | 0.0000055119 | OXYGEN TOXICITY//WINTHROP UNIV HOSP//HYPEROXIC LUNG INJURY |
| 10 | 0.0000049773 | INFECTION DRUG THERAPY MORTALITY//CORD BLOOD NEUTROPHILS//FK 409 |